Fundraising Fox

Neos Therapeutics

Grand Prairie, US · Founded 2009 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SL
Steven LutzVP Sales
CS
Carolyn SikesVP Clinical Affairs
RM
Russ McMahenVP Research and Development
MC
Margaret CabanoVP Operations
RE
Richard EisenstadtChief Financial Officer and Secretary
AM
Asif MughalVP Quality Assurance
MT
Mark TenglerChief Technology Officer
VM
Victor MillerVP Finance
VG
Vipin GargChief Executive Officer
EH
Ellen HoffingCo-President and Chief Operating Officer

Board

GR
Greg RobitailleBoard director
RI
Ralph IannelliBoard director

Investors · 1

Sofinnova VenturesMenlo Park · $100K – $15M

Reported raises · per SEC filings

Form D private placements

$38.6M disclosed across 3 rounds · 2013–2014

▶$20.6MraisedFeb 2015 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven LutzExecutive Officer
  • Carolyn SikesExecutive Officer
  • Arlen EwartExecutive Officer
  • Russ McMahenExecutive Officer
  • Stacie SwitzerExecutive Officer
  • Margaret CabanoExecutive Officer
  • Greg RobitailleDirector
  • Richard EisenstadtExecutive Officer
  • Alan HellerDirector
  • Asif MughalExecutive Officer
  • Mark TenglerExecutive Officer
  • Ralph IannelliDirector
  • Vipin GargExecutive Officer, Director
  • Bryant FongDirector
  • Edward SchnipperDirector
  • Dorothy EngelkingExecutive Officer
Offering amount
$20.6M
Amount sold
$20.6M
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedApr 2014 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark TenglerExecutive Officer
  • Alan HellerDirector
  • Greg RobitailleDirector
  • Russ McMahenExecutive Officer
  • Asif MughalExecutive Officer
  • Bryant FongDirector
  • Dorothy EngelkingExecutive Officer
  • Stacie SwitzerExecutive Officer
  • Arlen EwartExecutive Officer
  • Ralph IannelliDirector
  • Edward SchnipperDirector
  • Vipin GargDirector
  • Margaret CabanoExecutive Officer
  • Carolyn SikesExecutive Officer
  • Victor MillerExecutive Officer
Offering amount
$2.5M
Amount sold
$2.5M
First sale
Mar 2014
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.5MraisedMar 2014 · 25 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Asif MughalExecutive Officer
  • Bryant FongDirector
  • Greg RobitailleDirector
  • Victor MillerExecutive Officer
  • Carolyn SikesExecutive Officer
  • Alan HellerDirector
  • Margaret CabanoExecutive Officer
  • Vipin GargDirector
  • Stacie SwitzerExecutive Officer
  • Ralph IannelliDirector
  • Ellen HoffingExecutive Officer
  • Arlen EwartExecutive Officer
  • Dorothy EngelkingExecutive Officer
  • Mark TenglerExecutive Officer
  • Russ McMahenExecutive Officer
  • Edward SchnipperDirector
Offering amount
$15.5M
Amount sold
$15.5M
First sale
Dec 2013
Incorporated
Corporation, Delaware, 2009
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Is The Turnaround At Neos Therapeutics All Done? - Investing Whispererinvestingwhisperer.com · Dec 2019Has Neos Therapeutics Inc (NASDAQ:NEOS) Improved Earnings Growth In Recent Times? - Simply Wall St Newssimplywall.st · Jun 2018Biotech Neos Therapeutics Wraps Up $15.5 Million Funding Round - BioSpacebiospace.com · Mar 2014Buy Neos Therapeutics Stock – NEOS Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

Who are Neos Therapeutics's investors?
Neos Therapeutics's investors include Sofinnova Ventures.
How much funding has Neos Therapeutics raised?
Neos Therapeutics has disclosed $38.6M raised across 3 rounds.
Where is Neos Therapeutics headquartered?
Neos Therapeutics is headquartered in Grand Prairie, US.